Michele (Shelley) Trucksis, Ph.D, M.D
Michele (Shelley) Trucksis is the Executive Vice President and Chief Medical Officer of Seres Therapeutics, Inc. ("Seres"). Dr. Trucksis has 25 years of experience in medicine and infectious diseases. Prior to joining Seres, she served as Executive Director of Merck Research Laboratories with responsibility for clinical and global product development functions and development strategy in antibacterials, antifungals, and anti-cytomegalovirus drug candidates. Dr. Trucksis earned her B.S. in medical technology from Youngstown State University, her Ph.D. in biochemistry from Kent State University, and her M.D. from Case Western Reserve School of Medicine. She completed her internship and residency in Internal Medicine at Yale-New Haven Hospital and her infectious diseases fellowship training at the Massachusetts General Hospital of Harvard Medical School.
